Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Diagnostics (Basel, Switzerland)|September 14, 2024
Effects of Virtual Rehabilitation Training on Post-Stroke Executive and Praxis Skills and Depression Symptoms: A Quasi-Randomised Clinical TrialRosaria De Luca, Antonio Gangemi, Maria Grazia Maggio, et al.
Psychology, Health & Medicine|May 10, 2025
Analysis of the clinical-organizational pathway and well-being of obese patients undergoing bariatric surgery: impact on satisfaction and quality of lifeIrene Cappadona, Maria Pagano, Francesco Corallo, et al.
International Journal of Environmental Research and Public Health|November 4, 2020
COVID-19 Risk Management and Screening in the Penitentiary Facilities of the Salerno Province in Southern ItalyAntonio Maria Pagano, Aniello Maiese, Carmine Izzo, et al.
BJU International|February 28, 2012
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian surveyCristina Masini, Roberto Sabbatini, Camillo Porta, et al.
Cancers|October 17, 2020
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES StudyMaria Pagano, Luca Giovanni Ceresoli, Paolo Andrea Zucali, et al.
Disability and Rehabilitation. Assistive Technology|February 22, 2026
Low- and high-tech AAC approaches in severe acquired brain injury: an exploratory pilot studyRosaria De Luca, Antonio Gangemi, Rosa Angela Fabio, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry ExperienceKalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, et al.
Clinical Lung Cancer|April 12, 2020
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective StudyRoberta Minari, Giulia Mazzaschi, Paola Bordi, et al.
The Lancet. Oncology|September 9, 2021
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trialCarmine Pinto, Paolo Andrea Zucali, Maria Pagano, et al.
Cancers|April 23, 2022
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring <i>BRAF</i> Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E SubgroupsFabiana Perrone, Giulia Mazzaschi, Roberta Minari, et al.
Pageof 10